5‑Amino‑1MQ 10mg
? What 5‑Amino‑1MQ Is
5‑Amino‑1MQ (full name: 5‑amino‑1‑methylquinolinium) is a membrane‑permeable small molecule that inhibits the enzyme NNMT (nicotinamide N‑methyltransferase).
NNMT is heavily expressed in fat tissue and is linked to slowed metabolism, fat‑cell enlargement, and reduced NAD⁺ availability. By blocking NNMT, 5‑Amino‑1MQ increases NAD⁺ levels and activates SIRT1, a key metabolic and longevity‑related enzyme.
⚙️ How It Works (Mechanism)
-
Inhibits NNMT, preventing NAD⁺ depletion
-
Raises intracellular NAD⁺, improving mitochondrial function
-
Activates SIRT1, increasing fat oxidation
-
Shrinks adipocytes (fat cells) in animal models
This mechanism is why it’s studied for fat‑loss, metabolic health, and cellular‑energy research.
? Reported Research Benefits
Across available studies and reviews:
-
Reduced fat‑cell size and volume (>30–40% in animal models)
-
Improved insulin sensitivity
-
Increased NAD⁺ and SAM levels
-
Enhanced mitochondrial energy output
-
Potential muscle‑regeneration support (via NNMT inhibition)
Researchers often describe it as a “metabolic activator” rather than a stimulant.
? Common Research Stacks
Researchers often combine 5‑Amino‑1MQ with:
-
Ipamorelin + CJC‑1295 → metabolic + GH synergy
-
BPC‑157 + TB‑500 → recovery + recomposition
-
Epithalon + GHK‑Cu → cellular‑health + NAD⁺ synergy
⚠️ Notes & Limitations
-
Human clinical data is very limited
-
Most studies are animal or cell‑culture
-
Long‑term safety is not established